MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to MacroGenics Provides Update on Corporate Progress and Third Quarter 2020 Financial Results

Macrogenics (MGNX) Tops Q3 EPS by 27c, Revenues Beat

November 4, 2020 5:50 PM EST

Macrogenics (NASDAQ: MGNX) reported Q3 EPS of ($0.66), $0.27 better than the analyst estimate of ($0.93). Revenue for the quarter came in at $18.25 million versus the consensus estimate of $15.79 million.

MacroGenics continued the advancement of its portfolio of multiple clinical... More